GlassScriptPhysician profile
Doctor Goldstein
NPI 1295014991
$36,230.45
in general payments reported to CMS, 2019-2025
8 companies · $368 in 2025
The $368 reported for 2025 was more than what a typical Molecular Genetic Pathology (Pathology) provider received nationally (typical 2025 total: $225).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.87 · 2020: $270 · 2021: $2,800 · 2022: $7,635 · 2023: $19K · 2024: $6,551 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $14K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $8,100 · Consulting Fee: $2,398 · Food and Beverage: $910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $14,023.42 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $8,100.00 |
| Consulting Fee | $2,398.00 |
| Food and Beverage | $909.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cepheid | $18,260.73 | 2021-2024 | Genexpert |
| Roche Diagnostics Corporation | $15,025.09 | 2023-2024 | Bcm For Cobas 8100, Cobas Pro Ise Analytical Unit |
| Qiagen, LLC | $2,068.55 | 2021-2025 | |
| Beckman Coulter, INC. | $351.47 | 2024-2025 | Dxh 900 Hematology System |
| Becton, Dickinson and Company | $250.00 | 2020 | |
| Abbott Laboratories | $224.00 | 2019-2025 | Alinity M |
| Hologic Sales and Service, LLC | $50.61 | 2024-2025 | Aptima |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doctor Goldstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.